Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives) (Q66347327)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
clinical trial

    Statements

    short name
    Hallmark DUAL (English)
    0 references
    title
    A Phase 3 Study With Asunaprevir and Daclatasvir (DUAL) for Null or Partial Responders to Peginterferon Alfa and Ribavirin (P/R), Intolerant or Ineligible to P/R Subjects and Treatment-Naive Subjects With Chronic Hepatitis C Genotype 1b Infection (English)
    0 references
    medical condition
    hepatitis
    0 references
    hepatitis C
    0 references
    country
    Argentina
    0 references
    Australia
    0 references
    Austria
    0 references
    Canada
    0 references
    France
    0 references
    Germany
    0 references
    Ireland
    0 references
    Israel
    0 references
    Italy
    0 references
    Netherlands
    0 references
    New Zealand
    0 references
    Poland
    0 references
    Spain
    0 references
    Taiwan
    0 references
    United Kingdom
    0 references
    start time
    May 2012
    0 references
    end time
    October 2013
    0 references
    number of participants
    748
    0 references
    minimum age
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q66347327&oldid=2237190030"